ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,264, issued on Dec. 30, was assigned to Institute of Materia Medica, Chinese Academy of Medical Sciences (China).
"Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof" was invented by Heng Xu (Beijing), Xiaoguang Chen (Beijing), Songwen Lin (Beijing), Ming Ji (Beijing), Jing Jin (Beijing), Deyu Wu (Beijing), Chunyang Wang (Beijing) and Yuanhao Lv (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3...